An underground economy for unapproved slimming medications is propelled by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.
Investigational Treatment Gaining Traction Via Social Media
Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Followers are urged to contact these profiles directly for source information, while also receiving discount codes.
Thriving Commerce on Messaging Platforms
Separately, a flourishing market exists on Telegram, where groups with thousands of participants share comparison images, administration instructions and assertions of rapid British shipping. Vendors market the substance there before directing buyers to WhatsApp for transactions.
Understanding Retatrutide
Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.
Medical Professionals Express Worries
Nevertheless, doctors and chemists have cautions that the distribution of what remains an unlicensed medication in the UK is worrisome and could result in individuals injecting substances of uncertain source.
Several experts said the popularity for the experimental drug could be linked to the increasing cost of approved slimming treatments such as Mounjaro.
Regulatory Status and Enforcement
Selling the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unapproved medication that cannot be marketed or supplied for personal consumption under the British medical regulations.
Some content creators try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still violate pharmaceutical, marketing, and consumer regulations, risking penalties, legal action or prison.
Platform Reaction and Content Removal
Based on the social media company, the service has removed problematic content and banned associated hashtags and query recommendations. The company stated it was committed to maintaining the service secure and allocating resources in enhancing enforcement strategies.
Digital Marketplace Activities
Investigations also discovered groups with up to 9,000 members selling retatrutide using the platform's integrated search feature, which operates like a online catalog. Entering “retatrutide” immediately brings up groups with thousands of members, populated with images of weight loss, positive testimonials and step-by-step guides for mixing or administering at residence.
After minutes of entering one group, a vendor posted contact information, where most purchases take place. The seller provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one asked about body mass, medical conditions or previous experience.
Item Information and Costs
Inside these communities, messages display black plastic parcels with Royal Mail labels, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at home with sterile water, or pre-filled pens typically sold at £160 for 20 milligrams. When asked how much time a pen should be used, vendors give contradictory answers ranging from a few weeks to “depends on your body”.
Platform Moderation and Security Measures
A representative for the messaging service said it actively moderated dangerous material on its service including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are injecting substances they cannot confirm. Even if the research behind retatrutide is valid, these digital products may not include what they claim,” said Jason Murphy, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to recent price rises for approved weight-loss medications such as Mounjaro. “With costs increasing, patients are turning to social media. But counterfeit treatments are highly risky. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she explained.
Her staff has previously encountered patients injured by personal administration from unconfirmed sources. “We recognize the frustration, but buying from Telegram or WhatsApp is gambling with your health,” stated Wyllie. “These substances could be contaminated or improperly measured.”
Manufacturer Position
A spokesperson from Eli Lilly said retatrutide was in third stage clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they said, adding that any product “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may expose users to potentially serious health risks”.
